Jarne Elleholm, Chairman
Mr. Jarne Elleholm has more than 20 years experience in the pharmaceutical and life science industries at Vice President and CEO level with a record of achievement in strategic business development, restructuring and driving profitable growth. Jarne has served as CEO for the Biotech company Aresa A/S where he built up the organization and completed an IPO. Prior experience includes European Vice President for Whatman International, a LSE listed company, and CEO for Lundbeck Ltd. UK where he successfully launched several pharmaceutical products. Jarne holds an M.Com from Copenhagen Business School and an MBA from INSEAD.

Prof. Steen Kølvraa, MD
Prof. Steen Kølvraa is professor of Clinical Genetics at the University of Southern Denmark. His main research interest is cytogenetics and prenatal diagnostics with special emphasis on FISH techniques. Since 1998, he has focused much of his interest on the development of methods for prenatal diagnosis based on fetal cells in maternal blood, a topic on which he is a world-renowned expert. Prof. Kølvraa is co-founder of FCMB ApS and appointed SVP of Medicinal Affairs. Prof. Kølvraa is a highly respected scientist within his field. As the author of more than 150 articles in peer-reviewed journals and of 16 chapters in scientific literature, he is highly acknowledged in the scientific community for his considerable contribution.

Jørn Falch
Mr. Falch is a MD and has got several years experience from the pharma- and biotech industry and is project manager at Oestjysk Innovation. Mr. Falch serves on several boards for Oestjysk Innovation.